DGX
Quest DiagnosticsCNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
The bullish case is that Quest's Q1 2026 print showed broad operating strength: 9.2% revenue growth, 10.9% requisition volume growth, 13.1% adjusted EPS growth, and a full-year guide raise. If that volume cadence persists, the stock can still grind higher from the $196.31 anchor despite the immediate post-print reaction.
Posture
Mixed
Lead driver
Value
What changed
6 setup hits (3d) with net bullish as of 2026-06-03.
What can break
Advanced Diagnostics and consumer-channel growth may normalize after a strong quarter
Momentum
42
Value
62
Sentiment
47
Setup hits (3d)
6 · Net Bullish
AI TargetsBase $205.00 · Bull $225.00 · Bear $182.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-21 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $219.31
Why
Momentum42 · Δ7d -1.9
Value62 · Δ7d +0.1
Sentiment47 · Δ7d +4.8
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
42
34% active weight
Current posture
7d trendFlat
Δ7d
-1.9
Δ21d
+0.3
Value
62
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
47
33% active weight
Current posture
7d trendImproving
Δ7d
+4.8
Δ21d
+6.8
Why this grade
Composite grade C. Momentum 42.4 / Value 61.8 / Sentiment 47.5
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$21.38B
Beta
0.66
Shares Out
111.24M
P/E (TTM)
20.5
P/S (TTM)
1.78
P/FCF (TTM)
18.45
Rev YoY
+13.2%
EPS YoY
+8.0%
Gross Margin
+33.5%
Op Margin
+14.1%
Net Debt
$5.83B
Current Ratio
1.13
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology